Skip to content
mapperlab
← Dashboard
Stock

HCAT

HEALTH CATALYST, INC.
Latest close $1.342 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
2
27 funds tracked
Ever held
9
Current + past
New this quarter
1
Exited this quarter
3

Marquee-fund ownership over time

Nov 14, 2019Aug 14, 2024Nov 13, 2025May 15, 2026
Now
2

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Renaissance Technologies re-entered$6.65$1.34-80%
AQR Capital Management$6.32$1.34-79%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Two Sigma Investments 2× in & out→ $1.19-59%
D.E. Shaw 2× in & out→ $1.19-47%
Millennium Management→ $1.19-81%
Citadel Advisors→ $2.27-64%
Point72 Asset Management→ $4.11-35%
Bridgewater Associates→ $7.38-86%
Tiger Global→ $15-57%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Health Catalyst, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
6
Filings · last 90d
13
Total on file
505
Recent SEC buffer
Most recent
Jun 3, 2026

30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 505 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · HEALTH CATALYST, INC.

Annual figures sourced directly from HEALTH CATALYST, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$311.14M
FY2025+1% YoY
Net income
-$177.97M
FY2025-156% YoY
EPS (diluted)
$-2.55
FY2025-122% YoY
Free cash flow(?)
-$237K
FY2025-102% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Health Catalyst, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Renaissance TechnologiesQ2 2026open$1.17$1.27+9%
D.E. ShawQ4 2025Q2 2026$2.27$1.19-47%
Renaissance TechnologiesQ4 2025Q1 2026$2.35$1.84-22%
Two Sigma InvestmentsQ3 2025Q2 2026$2.92$1.19-59%
Two Sigma InvestmentsQ1 2025Q2 2025$5.42$4.11-24%
Citadel AdvisorsQ3 2024Q4 2025$6.32$2.27-64%
D.E. ShawQ3 2024Q3 2025$6.32$2.92-54%
AQR Capital ManagementQ3 2024open$6.32$1.27-80%
Millennium ManagementQ3 2024Q2 2026$6.32$1.19-81%
Point72 Asset ManagementQ3 2024Q2 2025$6.32$4.11-35%
Renaissance TechnologiesQ3 2024Q4 2024$6.65$8.66+30%
Bridgewater AssociatesQ3 2021Q4 2023$52$7.38-86%
Tiger GlobalQ4 2019Q2 2022$34$15-57%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.